Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT).Methods: A total of 940 patients (≥...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.661619/full |
id |
doaj-1b3ff168d62246b18c642b34588bcb32 |
---|---|
record_format |
Article |
spelling |
doaj-1b3ff168d62246b18c642b34588bcb322021-07-30T08:32:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-07-011210.3389/fphar.2021.661619661619Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective ObservationYanxia Qian0Bing Xu1Xiaodong Qian2Lu Cao3Yujia Cheng4Xinjian Liu5Xinjian Liu6Song Bai7Zhijun Han8Junhong Wang9Junhong Wang10Department of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, Northern Jiangsu Province Hospital and Clinical Medical College, Yangzhou University, Yangzhou, ChinaDepartment of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Pathogenic Microorganism, Nanjing Medical University, Nanjing, ChinaKey Laboratory of Antibody Technique of National Health Commission of China, Department of Pathogen Biology, Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, Xuyi People’s Hospital, Huai’an, ChinaDepartment of Laboratory Medicine, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University, Wuxi, ChinaDepartment of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, Xuyi People’s Hospital, Huai’an, ChinaPurpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT).Methods: A total of 940 patients (≥75 years) who received PCI and one-year DAPT were retrospectively enrolled into the study. The multivariable logistic regression analysis was conducted to identify risk factors of antiplatelet-related bleeding complications. The receiver operating characteristic (ROC) curve analysis and the Delong test were performed to obtain the optimized PRECISE-DAPT score.Results: It was observed that 89 (9.47%) patients suffered bleeding complications, while 37 (3.94%) of them had the Bleeding Academic Research Consortium (BARC, type ≥2) bleeding events. We stratified the PRECISE-DAPT score in tertiles (T1: ≤23; T2:24 to 32; T3: ≥33) and found that BARC ≥ 2 type bleeding occurred more frequently in T3 than in T1 and T2 (8.25 vs. 1.46% vs. 2.40%, p <0.05). The ROC curve analysis revealed that the PRECISE-DAPT score cutoff for BARC ≥2 type bleeding prediction was 33. In comparison with the current recommended cutoff score of 25 (AUC: 0.608, based on ROC analysis), the Delong test indicated significantly improved ability for predicting BARC ≥ 2 type bleeding events using the proposed cutoff value of 33, AUC of 0.676 (p = 0.03), and Brier Score of 0.04. The multivariable logistic regression analysis demonstrated that the PRECISE-DAPT score ≥ 33 [OR: 3.772; 95% CI (1.229, 11.578); p = 0.02] was associated with BARC ≥ 2 type bleeding event, along with a history of hemorrhagic stroke [OR: 6.806; 95% CI (1.465, 31.613); p = 0.014], peptic ulcer [OR: 3.871; 95% CI (1.378, 10.871); p = 0.01], and/or myocardial infarction [MI, OR: 3.081; 95% CI (1.140, 8.326); p = 0.027].Conclusion: A higher PRECISE-DAPT score of 33 might be a more reasonable cutoff value for predicting BARC ≥2 type bleeding risk in CAD patients (≥75 years). In addition, the history of hemorrhagic stroke, peptic ulcer, and myocardial infarction were identified as the risk factors of BARC ≥2 type bleeding events.https://www.frontiersin.org/articles/10.3389/fphar.2021.661619/fullbleeding riskdual antiplatelet therapyelderly patientsPRECISE-DAPT scorerisk factors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yanxia Qian Bing Xu Xiaodong Qian Lu Cao Yujia Cheng Xinjian Liu Xinjian Liu Song Bai Zhijun Han Junhong Wang Junhong Wang |
spellingShingle |
Yanxia Qian Bing Xu Xiaodong Qian Lu Cao Yujia Cheng Xinjian Liu Xinjian Liu Song Bai Zhijun Han Junhong Wang Junhong Wang Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation Frontiers in Pharmacology bleeding risk dual antiplatelet therapy elderly patients PRECISE-DAPT score risk factors |
author_facet |
Yanxia Qian Bing Xu Xiaodong Qian Lu Cao Yujia Cheng Xinjian Liu Xinjian Liu Song Bai Zhijun Han Junhong Wang Junhong Wang |
author_sort |
Yanxia Qian |
title |
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_short |
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_full |
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_fullStr |
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_full_unstemmed |
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_sort |
incidence and risk factors for antiplatelet therapy–related bleeding complications among elderly patients after coronary stenting: a multicenter retrospective observation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2021-07-01 |
description |
Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT).Methods: A total of 940 patients (≥75 years) who received PCI and one-year DAPT were retrospectively enrolled into the study. The multivariable logistic regression analysis was conducted to identify risk factors of antiplatelet-related bleeding complications. The receiver operating characteristic (ROC) curve analysis and the Delong test were performed to obtain the optimized PRECISE-DAPT score.Results: It was observed that 89 (9.47%) patients suffered bleeding complications, while 37 (3.94%) of them had the Bleeding Academic Research Consortium (BARC, type ≥2) bleeding events. We stratified the PRECISE-DAPT score in tertiles (T1: ≤23; T2:24 to 32; T3: ≥33) and found that BARC ≥ 2 type bleeding occurred more frequently in T3 than in T1 and T2 (8.25 vs. 1.46% vs. 2.40%, p <0.05). The ROC curve analysis revealed that the PRECISE-DAPT score cutoff for BARC ≥2 type bleeding prediction was 33. In comparison with the current recommended cutoff score of 25 (AUC: 0.608, based on ROC analysis), the Delong test indicated significantly improved ability for predicting BARC ≥ 2 type bleeding events using the proposed cutoff value of 33, AUC of 0.676 (p = 0.03), and Brier Score of 0.04. The multivariable logistic regression analysis demonstrated that the PRECISE-DAPT score ≥ 33 [OR: 3.772; 95% CI (1.229, 11.578); p = 0.02] was associated with BARC ≥ 2 type bleeding event, along with a history of hemorrhagic stroke [OR: 6.806; 95% CI (1.465, 31.613); p = 0.014], peptic ulcer [OR: 3.871; 95% CI (1.378, 10.871); p = 0.01], and/or myocardial infarction [MI, OR: 3.081; 95% CI (1.140, 8.326); p = 0.027].Conclusion: A higher PRECISE-DAPT score of 33 might be a more reasonable cutoff value for predicting BARC ≥2 type bleeding risk in CAD patients (≥75 years). In addition, the history of hemorrhagic stroke, peptic ulcer, and myocardial infarction were identified as the risk factors of BARC ≥2 type bleeding events. |
topic |
bleeding risk dual antiplatelet therapy elderly patients PRECISE-DAPT score risk factors |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2021.661619/full |
work_keys_str_mv |
AT yanxiaqian incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT bingxu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT xiaodongqian incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT lucao incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT yujiacheng incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT xinjianliu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT xinjianliu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT songbai incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT zhijunhan incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT junhongwang incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT junhongwang incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation |
_version_ |
1721247627019812864 |